Healthcare > Pharmaceutical11/12/2024 6:00 PM
While synthetic biology has considerably advanced in the past decade, cost continues to be a major factor in commercial viability. Saccharomyces cerevisiae is a commonly used microbial host in synthetic biology. These cultures can be grown to very high densities with high expression levels of target molecules, making S. cerevisiae a preferred candidate for cost-effective natural product synthesis.
In this webinar, the expert speakers demonstrate the seamless scale-up of a high-yield fermentation process from 250 mL to 5 L, enabled by extensive vessel characterization using cloud-connected bioreactors. The speakers will share insights into how utilizing S. cerevisiae provided an efficient and cost-effective scale-up method.
They will also present case studies that illustrate the steps taken to reduce costs and mitigate risks during the scale-up process. The attendees will also gain a comprehensive understanding of how cloud-connected bioreactors can dramatically accelerate the scale-up process in biomanufacturing. The speakers will then delve into practical troubleshooting methods, designed to address and overcome common challenges encountered during scale-up.
Moreover, the session will explore effective strategies for reducing costs and de-risking the scale-up process, equipping attendees with tools and knowledge needed to optimize production efficiency and ensure successful outcomes in their biomanufacturing projects.
Register for this webinar to discover how cloud-connected bioreactors are revolutionizing the scale-up process for biomanufacturing.
What You Will Learn
Attendees will learn about:
• How cloud-connected bioreactors can accelerate scale-up
• Troubleshooting methods to overcome scale-up challenges
• Strategies for reducing costs and de-risking scale-up
Who Should Attend?
This webinar will appeal to:
• Small-Mid-Large Biotech/Pharma
• Emerging biotechs and startups/Agricultural biotechnology firms
• Food Technology and fermentation-based food companies
• Biofuel and renewable chemical companies
• Research institutions and academia
• Bioprocess Engineers
• Head of Process Development/Innovation
• Upstream Process Development Scientists
• Formulation Scientists
• Product Development
• Consultants/R&D/Scientists/Formulators
Speakers: Andrew Horwitz, PhD, Vice President Research and Development, Inscripta; Kris Tyner, Senior Director, Bioprocess Sciences, Culture Biosciences.